A better way to purify peptide-based drugs

Feb 17, 2014 by Marcia Goodrich
A better way to purify peptide-based drugs
Members of Shiyue Fang's research team in his lab at Michigan Tech, where they developed a better process to purify peptides and other biomolecules.

(Phys.org) —Peptides are an intriguing class of drugs. They are made of amino acids, just as humans are, and because of their intimate relationship with our own biological molecules, they have the potential to fight some of the most intractable diseases, including cancer.

But they can be difficult and expensive to make. A year's worth of the anti-HIV peptide drug enfuvirtide costs $25,000. Now a chemist at Michigan Technological University has overcome an important hurdle in the manufacturing process by developing a quicker, simpler purification method. As a bonus, his technique also works on DNA.

The new technology separates perfect peptides from those that do not make the grade, says Shiyue Fang. During production, attach to each other in chains to form the desired peptide, but some of the chains are never completed. To separate these truncated peptides, Fang's team adds a polymerizable group of atoms to the mix.

These atoms bind to either the perfect peptides or the unfinished ones, but not to both. The polymerized peptides become insoluble and precipitate out of the solution. "Just take the solution out, and the peptides are separated," said Fang.

The method works in about two hours, much faster than a similar process Fang developed a few years ago. And it works equally well for DNA sequences.

Shiyue Fang

The process has other advantages. It is cheaper and requires less labor than existing peptide purification methods, it can handle large batches of at a time, and it generates less waste. "Other methods use a large amount of organic solvents, with a waste-to-product ratio of about 1,000:1. Our waste-to-product ratio is 50:1, maximum," said Fang. "And it takes less time."

Fang has been issued a patent for his discovery and is exploring its commercial potential. "I'm excited about the progress we've made," he said. "Peptide drugs are used to fight cancer, inflammation, diseases of the central nervous system, viral diseases like HIV. . . This gives us a chance to make a difference in people's lives."

Explore further: Molecular effectiveness of peptides from African medicinal plants decoded

More information: "Purification of Synthetic Peptides Using a Catching Full-Length Sequence by Polymerization Approach." Mingcui Zhang, Durga Pokharel, and Shiyue Fang. Organic Letters Article ASAP. DOI: 10.1021/ol403426u

add to favorites email to friend print save as pdf

Related Stories

Gifts from the Gila monster

Jun 01, 2011

Who would have thought that Gila monster saliva would be the inspiration for a blockbuster new drug for Type 2 diabetes? Or that medicines for chronic pain, heart attacks, high blood pressure and stroke would emerge from ...

Recommended for you

Protein glue shows potential for use with biomaterials

3 hours ago

Researchers at the University of Milan in Italy have shown that a synthetic protein called AGMA1 has the potential to promote the adhesion of brain cells in a laboratory setting. This could prove helpful ...

New tool identifies therapeutic proteins in a 'snap'

Aug 21, 2014

(Phys.org) —In human and bacterial cells, glycosylation – the chemical process of attaching complex sugar molecules to proteins – is as fundamental as it gets, affecting every biological mechanism from cell signaling ...

User comments : 0